Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « spike »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
spice < spike < spinal  Facettes :

List of bibliographic references indexed by spike

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000130 (2021) Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique]Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.
000203 (2021) F O Shode [Afrique du Sud] ; A S K. Idowu [Afrique du Sud] ; O J Uhomoibhi [Afrique du Sud] ; S. Sabiu [Afrique du Sud]Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000510 (2021) Smarajit Maiti [Inde] ; Amrita Banerjee [Inde]Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
000645 (2021) Riadh Badraoui [Arabie saoudite, Tunisie] ; Mohd Adnan [Arabie saoudite] ; Fevzi Bardakci [Arabie saoudite, Turquie] ; Mousa M. Alreshidi [Arabie saoudite]Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
000B65 (2020) Preeti Pandey [États-Unis] ; Jitendra Subhash Rane [Inde] ; Aroni Chatterjee [Inde] ; Abhijeet Kumar [Inde] ; Rajni Khan [Inde] ; Amresh Prakash [Inde] ; Shashikant Ray [Inde]Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development.
000C05 (2020) Rashi Srivastava ; Shubham Tripathi ; Sreepoorna Unni ; Arif Hussain ; Shafiul Haque ; Nandita Dasgupta ; Vineeta Singh ; Bhartendu Nath MishraSilybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies.
001625 (2020) Nan Wang [République populaire de Chine] ; Shengli Han [République populaire de Chine] ; Rui Liu [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Huaizhen He [République populaire de Chine] ; Yongjing Zhang [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yanni Lv [République populaire de Chine] ; Jue Wang [République populaire de Chine] ; Xiaowei Li [République populaire de Chine] ; Yuanyuan Ding [République populaire de Chine] ; Jia Fu [République populaire de Chine] ; Yajing Hou [République populaire de Chine] ; Wen Lu [République populaire de Chine] ; Weina Ma [République populaire de Chine] ; Yingzhuan Zhan [République populaire de Chine] ; Bingling Dai [République populaire de Chine] ; Jie Zhang [République populaire de Chine] ; Xiaoyan Pan [République populaire de Chine] ; Shiling Hu [République populaire de Chine] ; Jiapan Gao [République populaire de Chine] ; Qianqian Jia [République populaire de Chine] ; Liyang Zhang [République populaire de Chine] ; Shuai Ge [République populaire de Chine] ; Saisai Wang [République populaire de Chine] ; Peida Liang [République populaire de Chine] ; Tian Hu [République populaire de Chine] ; Jiayu Lu [République populaire de Chine] ; Xiangjun Wang [République populaire de Chine] ; Huaxin Zhou [République populaire de Chine] ; Wenjing Ta [République populaire de Chine] ; Yuejin Wang [République populaire de Chine] ; Shemin Lu [République populaire de Chine] ; Langchong He [République populaire de Chine]Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
001894 (2020) Moussa Sehailia [Algérie] ; Smain Chemat [Algérie]Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "spike" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "spike" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    spike
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021